Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg For adults with type 2 diabetes (T2D), along with diet and exercise to improve glycemic control, for adults with T2D and established CVD, to reduce risk of MACE (CV death, nonfatal MI, or nonfatal stroke), and for adults with T2D and chronic kidney disease, to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death
[1] [3] Healthcare providers should emphasize this guidance during prescribing discussions
This injectable medication mimics glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite, metabolism, and energy balance
The sulfurs (yellow) join to make the disulfide bridge
Common side effects of GLP-1 medications Understanding the most common GLP-1 side effects allows pharmacists to proactively counsel patients and set realistic expectations